UPDATE: The first bullet under the R01, R35, and R37 heading has been expanded to indicate the supplement can’t exceed the direct costs of the parent award.

We’re offering administrative supplements for equipment to select NIGMS-funded research projects, resources, centers, and core facilities. Funds are intended for the purchase of needed equipment that will enhance user access to the resource and/or the impact of the parent grant. The application deadline is March 1.

R01, R35, and R37 grantees:

• Funds are available for the purchase of single equipment systems with requested direct costs up to $250,000, as long as it doesn't exceed the direct costs of the parent award.

To continue our efforts to catalyze the modernization of biomedical research training and career development, we invite eligible institutions with NIGMS training (T32, T34), certain research education (R25), or institutional career development (K12) awards to apply for administrative supplements to develop and implement curricular, training, or administrative activities to enhance:

• Laboratory safety curriculum and a culture of safety in biomedical research training environments (NOT-GM-22-010)
• Safe and inclusive biomedical research training environments (NOT-GM-22-011)
• Undergraduate biomedical research training (NOT-GM-22-012) (T34 and R25 undergraduate programs only)
• Program evaluation capacity (NOT-GM-22-013)
• Mentoring in the research training environment (NOT-GM-22-014)
• Wellness and resilience (NOT-GM-22-015)

We’re offering another round of administrative supplements to provide summer research experiences for undergraduate students. These supplements are open to all NIGMS-funded investigators with active R01, R35, and R37 awards, including those in their final year of funding. We’ll accept requests under PA-20-272, Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional). The research experiences can be conducted remotely or in person, depending on the institutional policies of each applicant.

UPDATE: Learn more about noncompliance and withdrawal of applications by reading our Frequently Asked Questions.

We frequently come across compliance issues when reviewing NIGMS T32, T34, and K12 institutional training grant applications. We’re providing information to help applicants avoid the consequences of not following the funding opportunity announcement (FOA) instructions, which could result in the withdrawal of applications without review:

We’re pleased to share that the NIGMS National and Regional Resource Program (R24) funding opportunity announcement (FOA) has been reissued (PAR-22-065). This program began in 2019 to provide access to state-of-the-art facilities, equipment, technologies, research tools, and software that aren’t generally available to a large number of researchers. To date, the program has established 12 resources that serve the scientific community on a national or multistate regional basis and offer a breadth of technologies. Below, we highlight just a few. We encourage you to explore all of the resources made available through this program and to learn more about the new FOA on our National and Regional Resources webpage.  

Are you preparing a grant application for the Graduate Research Training Initiative for Student Enhancement (G-RISE) or the Initiative for Maximizing Student Development (IMSD) predoctoral institutional research training program? If so, please join our informational webinar to learn about the programs and application components. You’ll also have the opportunity to ask us questions:

Friday, December 3, 1:30-3:00 p.m. ET

We’re hosting a webinar for Postbaccalaureate Research Education Program (PREP) (PAR-20-066) applicants:

Tuesday, November 30, 1:00-2:30 p.m. ET

We’re pleased to announce that the IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) funding announcement (RFA-GM-22-001) has been issued. The purpose of this initiative is to provide support for eligible small business concerns in each of the IDeA regions (Central, Northeast, Southeast, and West) to develop educational products promoting biomedical entrepreneurship in IDeA-eligible states. These products are expected to help academic institutions in these states translate scientific discoveries and technologies from research laboratories into commercial products.

The application due date is January 5, 2022.

If you’re planning to apply for a Phase 1, 2, or 3 Centers of Biomedical Research Excellence (COBRE) grant, it’s important that you attend our upcoming webinar:

Wednesday, October 27, 3:00-4:30 p.m. ET

During the webinar, we’ll present an overview of the COBRE program’s objectives, eligibility and reporting requirements, and other key aspects of the funding opportunity announcements. We’ll also answer any questions that you have.

We’re pleased to announce that we’ve published two notices of special interest (NOSI) calling for applications to PAR-19-313, Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional), that focus on research on women’s health (NOT-GM-21-056) and data sciences (NOT-GM-21-062).

These NOSIs highlight the Office of Research on Women's Health's interest in supporting a meritorious application on women's health, and the Office of Data Science Strategy’s interest in supporting a meritorious application on data science relevant to biomedical research. Applications for these NOSIs must be submitted in response to and meet all eligibility criteria of PAR-19-313.